Systematic Evaluation of HLA-G 3’Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome

Despite major improvements in diagnostics and therapy in early as well as in locally advanced breast cancer (LABC), metastatic relapse occurs in about 20% of patients, often explained by early micro-metastatic spread into bone marrow by disseminated tumor cells (DTC). Although neoadjuvant chemothera...

Descripció completa

Dades bibliogràfiques

Autors principals:	Vera Rebmann, Esther Schwich, Rafael Tomoya Michita, Lisa Grüntkemeier, Ann-Kathrin Bittner, Hana Rohn, Peter A. Horn, Oliver Hoffmann, Rainer Kimmig, Sabine Kasimir-Bauer
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-01-01
Col·lecció:	Frontiers in Immunology
Matèries:	HLA-G HLA-G UTR-4 breast cancer HLA-G 3’UTR polymorphism HLA-G UTR-2 HLA-G UTR-1
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.817132/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!